Leading the way to safer medication
 Crosscheck  Recommender

Azelastine

Description

Azelastine, a phthalazinone derivative is classified as a potent long-acting anti-allergic compound with selective H1 antagonist properties. An additional anti-inflammatory effect could be detected after topical ocular administration. Data from in vivo (pre-clinical) and in vitro studies show that azelastine inhibits the synthesis or release of the chemical mediators known to be involved in early and late stage allergic reactions e.g. leukotriene, histamine, PAF and serotonin.

ATC Classification

Code
Title
Category
R01AC03
Azelastine
R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids
R06AX19
Azelastine
R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
S01GX07
Azelastine
S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics

Trade names

Trade name
Countries
AFLUON

Cyprus Spain

ALLERGODIL

Austria France Netherlands

ALLERGODROP

Austria

ALLERGOSPRAY

Austria

ASTEPRO

Austria United States

AZEDIL

Austria

AZELA-VISION

Austria

AZEP

Singapore

OPTILAST

United Kingdom

POLLIVAL

Netherlands

RHINOLAST

United Kingdom

TEBARAT

Spain

VIVIDRIN AZELASTIN

Austria

Trade names (in combination): DYMISTA SYNAZE

Product Monographs

Monograph
Type
Country
Rhinolast Allergy 0.1% w/v Nasal Spray
MPI, EU: SmPC
UK
OPTILAST Eye drops
MPI, EU: SmPC
UK

2D Molecule Structure

Unique Ingredient Identifier (UNII)

ZQI909440X - AZELASTINE

CAS Registry Number

58581-89-8 - azelastine

SNOMED-CT

372520005 - Azelastine (substance)

 
Next: Usage >